APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadobutrol

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gadobutrol Market Outlook and Growth Opportunities 2026

23 December 2025198 pages

Choose your research edition.

Industry ResearchGadobutrol Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadobutrol Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Gadobutrol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadobutrol Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadobutrol Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Gadobutrol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gadobutrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadobutrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadobutrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gadobutrol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gadobutrol market include JinYan Chemicals (ShangHai), Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, MedKoo Biosciences, Manus Aktteva Biopharma, LGM Pharma, Jilin Tely Imp & Exp, BOC Sciences and Advanced Technology & Industrail, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadobutrol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadobutrol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadobutrol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadobutrol market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadobutrol Segment by Company

JinYan Chemicals (ShangHai)

Bayer HealthCare Pharmaceuticals

SWAPNROOP DRUGS & PHARMACEUTICALS

MedKoo Biosciences

Manus Aktteva Biopharma

LGM Pharma

Jilin Tely Imp & Exp

BOC Sciences

Advanced Technology & Industrail

Gadobutrol Segment by Type

Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)

Pharmacy Bulk Packages (30 mL and 65 mL)

Gadobutrol Segment by Application

Adults

Children

Gadobutrol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gadobutrol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gadobutrol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gadobutrol significant trends, drivers, influence factors in global and regions.

6. To analyze Gadobutrol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadobutrol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadobutrol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadobutrol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadobutrol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gadobutrol industry.

Chapter 3: Detailed analysis of Gadobutrol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gadobutrol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gadobutrol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gadobutrol Industry Trends Table 2. Gadobutrol Industry Drivers Table 3. Gadobutrol Industry Opportunities and Challenges Table 4. Gadobutrol Industry Restraints Table 5. Global Gadobutrol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gadobutrol Revenue Share by Company (2021-2026) Table 7. Global Gadobutrol Sales Volume by Company (m L) & (2021-2026) Table 8. Global Gadobutrol Sales Volume Share by Company (2021-2026) Table 9. Global Gadobutrol Average Price (US$/L) of Company (2021-2026) Table 10. Global Gadobutrol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gadobutrol Key Company Manufacturing Base & Headquarters Table 12. Global Gadobutrol Company, Product Type & Application Table 13. Global Gadobutrol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadobutrol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) Table 18. Significant Companies of Pharmacy Bulk Packages (30 mL and 65 mL) Table 19. Global Gadobutrol Sales Volume by Type 2021 VS 2025 VS 2032 (m L) Table 20. Global Gadobutrol Sales Volume by Type (2021-2026) & (m L) Table 21. Global Gadobutrol Sales Volume by Type (2027-2032) & (m L) Table 22. Global Gadobutrol Sales Volume Share by Type (2021-2026) Table 23. Global Gadobutrol Sales Volume Share by Type (2027-2032) Table 24. Global Gadobutrol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gadobutrol Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gadobutrol Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gadobutrol Sales Value Share by Type (2021-2026) Table 28. Global Gadobutrol Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adults Table 30. Significant Companies of Children Table 31. Global Gadobutrol Sales Volume by Application 2021 VS 2025 VS 2032 (m L) Table 32. Global Gadobutrol Sales Volume by Application (2021-2026) & (m L) Table 33. Global Gadobutrol Sales Volume by Application (2027-2032) & (m L) Table 34. Global Gadobutrol Sales Volume Share by Application (2021-2026) Table 35. Global Gadobutrol Sales Volume Share by Application (2027-2032) Table 36. Global Gadobutrol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Gadobutrol Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Gadobutrol Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Gadobutrol Sales Value Share by Application (2021-2026) Table 40. Global Gadobutrol Sales Value Share by Application (2027-2032) Table 41. Global Gadobutrol Sales by Region: 2021 VS 2025 VS 2032 (m L) Table 42. Global Gadobutrol Sales by Region (2021-2026) & (m L) Table 43. Global Gadobutrol Sales Market Share by Region (2021-2026) Table 44. Global Gadobutrol Sales by Region (2027-2032) & (m L) Table 45. Global Gadobutrol Sales Market Share by Region (2027-2032) Table 46. Global Gadobutrol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gadobutrol Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Gadobutrol Sales Value Share by Region (2021-2026) Table 49. Global Gadobutrol Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Gadobutrol Sales Value Share by Region (2027-2032) Table 51. Global Gadobutrol Market Average Price (US$/L) by Region (2021-2026) Table 52. Global Gadobutrol Market Average Price (US$/L) by Region (2027-2032) Table 53. Global Gadobutrol Sales by Country: 2021 VS 2025 VS 2032 (m L) Table 54. Global Gadobutrol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Gadobutrol Sales by Country (2021-2026) & (m L) Table 56. Global Gadobutrol Sales Market Share by Country (2021-2026) Table 57. Global Gadobutrol Sales by Country (2027-2032) & (m L) Table 58. Global Gadobutrol Sales Market Share by Country (2027-2032) Table 59. Global Gadobutrol Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Gadobutrol Sales Value Market Share by Country (2021-2026) Table 61. Global Gadobutrol Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Gadobutrol Sales Value Market Share by Country (2027-2032) Table 63. JinYan Chemicals (ShangHai) Company Information Table 64. JinYan Chemicals (ShangHai) Business Overview Table 65. JinYan Chemicals (ShangHai) Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 66. JinYan Chemicals (ShangHai) Gadobutrol Product Portfolio Table 67. JinYan Chemicals (ShangHai) Recent Development Table 68. Bayer HealthCare Pharmaceuticals Company Information Table 69. Bayer HealthCare Pharmaceuticals Business Overview Table 70. Bayer HealthCare Pharmaceuticals Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 71. Bayer HealthCare Pharmaceuticals Gadobutrol Product Portfolio Table 72. Bayer HealthCare Pharmaceuticals Recent Development Table 73. SWAPNROOP DRUGS & PHARMACEUTICALS Company Information Table 74. SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview Table 75. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 76. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol Product Portfolio Table 77. SWAPNROOP DRUGS & PHARMACEUTICALS Recent Development Table 78. MedKoo Biosciences Company Information Table 79. MedKoo Biosciences Business Overview Table 80. MedKoo Biosciences Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 81. MedKoo Biosciences Gadobutrol Product Portfolio Table 82. MedKoo Biosciences Recent Development Table 83. Manus Aktteva Biopharma Company Information Table 84. Manus Aktteva Biopharma Business Overview Table 85. Manus Aktteva Biopharma Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 86. Manus Aktteva Biopharma Gadobutrol Product Portfolio Table 87. Manus Aktteva Biopharma Recent Development Table 88. LGM Pharma Company Information Table 89. LGM Pharma Business Overview Table 90. LGM Pharma Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 91. LGM Pharma Gadobutrol Product Portfolio Table 92. LGM Pharma Recent Development Table 93. Jilin Tely Imp & Exp Company Information Table 94. Jilin Tely Imp & Exp Business Overview Table 95. Jilin Tely Imp & Exp Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 96. Jilin Tely Imp & Exp Gadobutrol Product Portfolio Table 97. Jilin Tely Imp & Exp Recent Development Table 98. BOC Sciences Company Information Table 99. BOC Sciences Business Overview Table 100. BOC Sciences Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 101. BOC Sciences Gadobutrol Product Portfolio Table 102. BOC Sciences Recent Development Table 103. Advanced Technology & Industrail Company Information Table 104. Advanced Technology & Industrail Business Overview Table 105. Advanced Technology & Industrail Gadobutrol Sales (m L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 106. Advanced Technology & Industrail Gadobutrol Product Portfolio Table 107. Advanced Technology & Industrail Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Gadobutrol Distributors List Table 111. Gadobutrol Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Gadobutrol Product Image Figure 2. Global Gadobutrol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadobutrol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gadobutrol Sales (2021-2032) & (m L) Figure 5. Global Gadobutrol Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Gadobutrol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) Image Figure 10. Pharmacy Bulk Packages (30 mL and 65 mL) Image Figure 11. Global Gadobutrol Sales Volume by Type (2021 VS 2025 VS 2032) & (m L) Figure 12. Global Gadobutrol Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gadobutrol Sales Volume Share by Type (2021-2032) Figure 14. Global Gadobutrol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gadobutrol Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gadobutrol Sales Value Share by Type (2021-2032) Figure 17. Adults Image Figure 18. Children Image Figure 19. Global Gadobutrol Sales Volume by Application (2021 VS 2025 VS 2032) & (m L) Figure 20. Global Gadobutrol Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Gadobutrol Sales Volume Share by Application (2021-2032) Figure 22. Global Gadobutrol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gadobutrol Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Gadobutrol Sales Value Share by Application (2021-2032) Figure 25. Global Gadobutrol Sales by Region: 2021 VS 2025 VS 2032 (m L) Figure 26. Global Gadobutrol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Gadobutrol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Gadobutrol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Gadobutrol Sales Value (2021-2032) & (US$ Million) Figure 30. North America Gadobutrol Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Gadobutrol Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Gadobutrol Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Gadobutrol Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Gadobutrol Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Gadobutrol Sales Value (2021-2032) & (US$ Million) Figure 36. South America Gadobutrol Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Gadobutrol Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Gadobutrol Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Gadobutrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Gadobutrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Gadobutrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Gadobutrol Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Gadobutrol Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
  • Pharmacy Bulk Packages (30 mL and 65 mL)
Applications
  • Adults
  • Children
Companies covered
  • JinYan Chemicals (ShangHai)
  • Bayer HealthCare Pharmaceuticals
  • SWAPNROOP DRUGS & PHARMACEUTICALS
  • MedKoo Biosciences
  • Manus Aktteva Biopharma
  • LGM Pharma
  • Jilin Tely Imp & Exp
  • BOC Sciences
  • Advanced Technology & Industrail

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadobutrol Sales Value (2021-2032)
  4. 1.2.2 Global Gadobutrol Sales Volume (2021-2032)
  5. 1.2.3 Global Gadobutrol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gadobutrol Market Dynamics
  1. 2.1 Gadobutrol Industry Trends
  2. 2.2 Gadobutrol Industry Drivers
  3. 2.3 Gadobutrol Industry Opportunities and Challenges
  4. 2.4 Gadobutrol Industry Restraints
3 Gadobutrol Market by Company
  1. 3.1 Global Gadobutrol Company Revenue Ranking in 2025
  2. 3.2 Global Gadobutrol Revenue by Company (2021-2026)
  3. 3.3 Global Gadobutrol Sales Volume by Company (2021-2026)
  4. 3.4 Global Gadobutrol Average Price by Company (2021-2026)
  5. 3.5 Global Gadobutrol Company Ranking (2024-2026)
  6. 3.6 Global Gadobutrol Company Manufacturing Base and Headquarters
  7. 3.7 Global Gadobutrol Company Product Type and Application
  8. 3.8 Global Gadobutrol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gadobutrol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gadobutrol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gadobutrol Market by Type
  1. 4.1 Gadobutrol Type Introduction
  2. 4.1.1 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
  3. 4.1.2 Pharmacy Bulk Packages (30 mL and 65 mL)
  4. 4.2 Global Gadobutrol Sales Volume by Type
  5. 4.2.1 Global Gadobutrol Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gadobutrol Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gadobutrol Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gadobutrol Sales Value by Type
  9. 4.3.1 Global Gadobutrol Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gadobutrol Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gadobutrol Sales Value Share by Type (2021-2032)
5 Gadobutrol Market by Application
  1. 5.1 Gadobutrol Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Gadobutrol Sales Volume by Application
  5. 5.2.1 Global Gadobutrol Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gadobutrol Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Gadobutrol Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Gadobutrol Sales Value by Application
  9. 5.3.1 Global Gadobutrol Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gadobutrol Sales Value by Application (2021-2032)
  11. 5.3.3 Global Gadobutrol Sales Value Share by Application (2021-2032)
6 Gadobutrol Regional Sales and Value Analysis
  1. 6.1 Global Gadobutrol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadobutrol Sales by Region (2021-2032)
  3. 6.2.1 Global Gadobutrol Sales by Region: 2021-2026
  4. 6.2.2 Global Gadobutrol Sales by Region (2027-2032)
  5. 6.3 Global Gadobutrol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gadobutrol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gadobutrol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gadobutrol Sales Value by Region (2027-2032)
  9. 6.5 Global Gadobutrol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gadobutrol Sales Value (2021-2032)
  12. 6.6.2 North America Gadobutrol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gadobutrol Sales Value (2021-2032)
  15. 6.7.2 Europe Gadobutrol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gadobutrol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gadobutrol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gadobutrol Sales Value (2021-2032)
  21. 6.9.2 South America Gadobutrol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gadobutrol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gadobutrol Sales Value Share by Country, 2025 VS 2032
7 Gadobutrol Country-level Sales and Value Analysis
  1. 7.1 Global Gadobutrol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gadobutrol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gadobutrol Sales by Country (2021-2032)
  4. 7.3.1 Global Gadobutrol Sales by Country (2021-2026)
  5. 7.3.2 Global Gadobutrol Sales by Country (2027-2032)
  6. 7.4 Global Gadobutrol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gadobutrol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gadobutrol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gadobutrol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gadobutrol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gadobutrol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gadobutrol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gadobutrol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gadobutrol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gadobutrol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gadobutrol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gadobutrol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gadobutrol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gadobutrol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gadobutrol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gadobutrol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gadobutrol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gadobutrol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gadobutrol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gadobutrol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gadobutrol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gadobutrol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gadobutrol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gadobutrol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gadobutrol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gadobutrol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gadobutrol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gadobutrol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gadobutrol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gadobutrol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gadobutrol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gadobutrol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gadobutrol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gadobutrol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gadobutrol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gadobutrol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gadobutrol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gadobutrol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gadobutrol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gadobutrol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gadobutrol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gadobutrol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gadobutrol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gadobutrol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gadobutrol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gadobutrol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gadobutrol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gadobutrol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gadobutrol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gadobutrol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gadobutrol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gadobutrol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gadobutrol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gadobutrol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gadobutrol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gadobutrol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gadobutrol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gadobutrol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gadobutrol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gadobutrol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gadobutrol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gadobutrol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gadobutrol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gadobutrol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gadobutrol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gadobutrol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gadobutrol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gadobutrol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gadobutrol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gadobutrol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gadobutrol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gadobutrol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gadobutrol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gadobutrol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gadobutrol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gadobutrol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gadobutrol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gadobutrol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gadobutrol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gadobutrol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gadobutrol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gadobutrol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gadobutrol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gadobutrol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gadobutrol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gadobutrol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gadobutrol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 JinYan Chemicals (ShangHai)
  2. 8.1.1 JinYan Chemicals (ShangHai) Company Information
  3. 8.1.2 JinYan Chemicals (ShangHai) Business Overview
  4. 8.1.3 JinYan Chemicals (ShangHai) Gadobutrol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 JinYan Chemicals (ShangHai) Gadobutrol Product Portfolio
  6. 8.1.5 JinYan Chemicals (ShangHai) Recent Developments
  7. 8.2 Bayer HealthCare Pharmaceuticals
  8. 8.2.1 Bayer HealthCare Pharmaceuticals Company Information
  9. 8.2.2 Bayer HealthCare Pharmaceuticals Business Overview
  10. 8.2.3 Bayer HealthCare Pharmaceuticals Gadobutrol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare Pharmaceuticals Gadobutrol Product Portfolio
  12. 8.2.5 Bayer HealthCare Pharmaceuticals Recent Developments
  13. 8.3 SWAPNROOP DRUGS & PHARMACEUTICALS
  14. 8.3.1 SWAPNROOP DRUGS & PHARMACEUTICALS Company Information
  15. 8.3.2 SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
  16. 8.3.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol Product Portfolio
  18. 8.3.5 SWAPNROOP DRUGS & PHARMACEUTICALS Recent Developments
  19. 8.4 MedKoo Biosciences
  20. 8.4.1 MedKoo Biosciences Company Information
  21. 8.4.2 MedKoo Biosciences Business Overview
  22. 8.4.3 MedKoo Biosciences Gadobutrol Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MedKoo Biosciences Gadobutrol Product Portfolio
  24. 8.4.5 MedKoo Biosciences Recent Developments
  25. 8.5 Manus Aktteva Biopharma
  26. 8.5.1 Manus Aktteva Biopharma Company Information
  27. 8.5.2 Manus Aktteva Biopharma Business Overview
  28. 8.5.3 Manus Aktteva Biopharma Gadobutrol Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Manus Aktteva Biopharma Gadobutrol Product Portfolio
  30. 8.5.5 Manus Aktteva Biopharma Recent Developments
  31. 8.6 LGM Pharma
  32. 8.6.1 LGM Pharma Company Information
  33. 8.6.2 LGM Pharma Business Overview
  34. 8.6.3 LGM Pharma Gadobutrol Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LGM Pharma Gadobutrol Product Portfolio
  36. 8.6.5 LGM Pharma Recent Developments
  37. 8.7 Jilin Tely Imp & Exp
  38. 8.7.1 Jilin Tely Imp & Exp Company Information
  39. 8.7.2 Jilin Tely Imp & Exp Business Overview
  40. 8.7.3 Jilin Tely Imp & Exp Gadobutrol Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Tely Imp & Exp Gadobutrol Product Portfolio
  42. 8.7.5 Jilin Tely Imp & Exp Recent Developments
  43. 8.8 BOC Sciences
  44. 8.8.1 BOC Sciences Company Information
  45. 8.8.2 BOC Sciences Business Overview
  46. 8.8.3 BOC Sciences Gadobutrol Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BOC Sciences Gadobutrol Product Portfolio
  48. 8.8.5 BOC Sciences Recent Developments
  49. 8.9 Advanced Technology & Industrail
  50. 8.9.1 Advanced Technology & Industrail Company Information
  51. 8.9.2 Advanced Technology & Industrail Business Overview
  52. 8.9.3 Advanced Technology & Industrail Gadobutrol Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Advanced Technology & Industrail Gadobutrol Product Portfolio
  54. 8.9.5 Advanced Technology & Industrail Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadobutrol Value Chain Analysis
  2. 9.1.1 Gadobutrol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadobutrol Sales Mode & Process
  6. 9.2 Gadobutrol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadobutrol Distributors
  9. 9.2.3 Gadobutrol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst